DK3365346T3 - Oxa-diazaspiroforbindelser med aktivitet mod smerter - Google Patents

Oxa-diazaspiroforbindelser med aktivitet mod smerter Download PDF

Info

Publication number
DK3365346T3
DK3365346T3 DK16784795.3T DK16784795T DK3365346T3 DK 3365346 T3 DK3365346 T3 DK 3365346T3 DK 16784795 T DK16784795 T DK 16784795T DK 3365346 T3 DK3365346 T3 DK 3365346T3
Authority
DK
Denmark
Prior art keywords
oxa
activity against
against pain
diazaspiro compounds
diazaspiro
Prior art date
Application number
DK16784795.3T
Other languages
English (en)
Inventor
Marina Virgili-Bernado
Carmen Almansa-Rosales
Carlos Alegret-Molina
Original Assignee
Esteve Pharmaceuticals Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Esteve Pharmaceuticals Sa filed Critical Esteve Pharmaceuticals Sa
Application granted granted Critical
Publication of DK3365346T3 publication Critical patent/DK3365346T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/10Spiro-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42Oxazoles
    • A61K31/424Oxazoles condensed with heterocyclic ring systems, e.g. clavulanic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DK16784795.3T 2015-10-23 2016-10-21 Oxa-diazaspiroforbindelser med aktivitet mod smerter DK3365346T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP15382523 2015-10-23
PCT/EP2016/001742 WO2017067664A1 (en) 2015-10-23 2016-10-21 Oxa-diazaspiro compounds having activity against pain

Publications (1)

Publication Number Publication Date
DK3365346T3 true DK3365346T3 (da) 2020-03-09

Family

ID=54364221

Family Applications (1)

Application Number Title Priority Date Filing Date
DK16784795.3T DK3365346T3 (da) 2015-10-23 2016-10-21 Oxa-diazaspiroforbindelser med aktivitet mod smerter

Country Status (30)

Country Link
US (1) US10689398B2 (da)
EP (1) EP3365346B1 (da)
JP (1) JP6884973B2 (da)
KR (1) KR20180073638A (da)
CN (1) CN108349998B (da)
AR (1) AR106448A1 (da)
AU (1) AU2016343551A1 (da)
BR (1) BR112018007269A2 (da)
CA (1) CA2999925A1 (da)
CO (1) CO2018004803A2 (da)
CY (1) CY1122708T1 (da)
DK (1) DK3365346T3 (da)
ES (1) ES2775522T3 (da)
HR (1) HRP20200309T1 (da)
HU (1) HUE047997T2 (da)
IL (1) IL258370A (da)
LT (1) LT3365346T (da)
MA (1) MA43158B1 (da)
ME (1) ME03636B (da)
MX (1) MX2018004777A (da)
PH (1) PH12018500682A1 (da)
PL (1) PL3365346T3 (da)
PT (1) PT3365346T (da)
RS (1) RS59956B1 (da)
RU (1) RU2018118399A (da)
SG (1) SG11201802988XA (da)
SI (1) SI3365346T1 (da)
TN (1) TN2018000091A1 (da)
TW (1) TW201731853A (da)
WO (1) WO2017067664A1 (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW201615643A (zh) 2014-06-02 2016-05-01 伊史帝夫博士實驗室股份有限公司 具有多重模式抗疼痛活性之1-氧雜-4,9-二氮雜螺十一烷化合物之烷基與芳基衍生物
US10689398B2 (en) 2015-10-23 2020-06-23 Esteve Pharmaceuticals, S.A. OXA-Diazaspiro compounds having activity against pain

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3481942A (en) 1968-09-06 1969-12-02 Smithkline Corp Oxa-diazaspiro(4.5)decane compounds
US4353900A (en) * 1981-10-19 1982-10-12 Syntex (U.S.A.) Inc. 9-(Arylalkyl or aroylalkyl)-1-oxa-4,9-diazaspiro(5.5)undecan-3-ones
WO1993013101A1 (en) * 1991-12-27 1993-07-08 Yoshitomi Pharmaceutical Industries, Ltd. Pyridonecarboxylate compound, pharmaceutical use thereof, and spiro compound
US6114541A (en) 1997-03-10 2000-09-05 Hoffmann-La Roche Inc. Method for the preparation of α-Bromo-Lactam derivatives
WO2003057698A2 (en) 2001-12-28 2003-07-17 Acadia Pharmaceuticals, Inc. Spiroazacyclic compounds as monoamine receptor modulators
WO2005046589A2 (en) * 2003-11-07 2005-05-26 Chiron Corporation Pharmaceutically acceptable salts of quinolinone compounds having improved pharmaceutical properties
EP1634873A1 (en) 2004-08-27 2006-03-15 Laboratorios Del Dr. Esteve, S.A. Sigma receptor inhibitors
DE102005030051A1 (de) 2005-06-27 2006-12-28 Grünenthal GmbH Substituierte 1-Oxa-3,8-diazaspiro[4,5]-decan-2-on-Verbindungen und deren Verwendung zur Herstellung von Arzneimitteln
PL1961744T3 (pl) 2005-11-18 2013-09-30 Ono Pharmaceutical Co Związek zawierający grupę zasadową oraz jego zastosowanie
EP1829869A1 (en) 2006-03-02 2007-09-05 Laboratorios Del Dr. Esteve, S.A. 4,5,6,7-Tetrahydrobenzo[b]thiophene derivatives and their use as sigma receptor ligands
WO2007124136A1 (en) 2006-04-19 2007-11-01 Acadia Pharmaceuticals, Inc. Use of 4-amino-piperidines for treating sleep disorders
EP1847542A1 (en) 2006-04-21 2007-10-24 Laboratorios del Dr. Esteve S.A. Spiro[benzopyran] or spiro[benzofuran] derivatives which inhibit the sigma receptor
JP5313865B2 (ja) 2007-03-01 2013-10-09 田辺三菱製薬株式会社 ベンゾイミダゾール化合物およびその医薬用途
EP1982714A1 (en) 2007-04-16 2008-10-22 Laboratorios del Dr. Esteve S.A. Pyrano-pyrazole-amines
EP2020414A1 (en) 2007-06-20 2009-02-04 Laboratorios del Dr. Esteve S.A. spiro[piperidine-4,4'-thieno[3,2-c]pyran] derivatives and related compounds as inhibitors of the sigma receptor for the treatment of psychosis
US20110190280A1 (en) 2007-08-29 2011-08-04 George Adjabeng Thiazole And Oxazole Kinase Inhibitors
EP2070933A1 (en) 2007-12-07 2009-06-17 Laboratorios del Dr. Esteve S.A. Tricyclic triazolic compounds
KR101273200B1 (ko) 2008-02-06 2013-06-17 펄마젠 쎄라퓨틱스 (시너지) 리미티드 화합물
CN102668581A (zh) 2009-10-25 2012-09-12 Lg电子株式会社 用于处理广播节目信息的方法及广播接收器
CN103517910B (zh) * 2011-03-14 2016-12-14 沃泰克斯药物股份有限公司 作为离子通道调节剂的吗啉-螺环哌啶酰胺
US8940085B2 (en) 2011-03-16 2015-01-27 Access Business Group International Llc Humidifier with ultraviolet disinfection
JP5964426B2 (ja) 2011-08-19 2016-08-03 グラクソスミスクライン、インテレクチュアル、プロパティー、ナンバー2、リミテッドGlaxosmithkline Intellectual Property No.2 Limited 脂肪酸シンターゼ阻害剤
EP3027625B1 (en) 2013-07-31 2018-05-30 Merck Sharp & Dohme Corp. Spiro-fused derivatives of piperidine useful for the treatment of inter alia hypertension and acute or chronic heart failure
JP2017100951A (ja) 2014-04-04 2017-06-08 大正製薬株式会社 オキサゾリジノン及びオキサジナノン誘導体
TW201615642A (zh) 2014-06-02 2016-05-01 伊史帝夫博士實驗室股份有限公司 具有多重模式抗疼痛活性的1-氧雜-4,9-二氮雜螺十一烷化合物之醯胺衍生物
TWI685497B (zh) 2014-06-02 2020-02-21 西班牙商伊史帝夫製藥公司 具有多重模式抗疼痛活性的1-氧雜-4,9-二氮雜螺十一烷化合物之烷基衍生物
TW201615643A (zh) * 2014-06-02 2016-05-01 伊史帝夫博士實驗室股份有限公司 具有多重模式抗疼痛活性之1-氧雜-4,9-二氮雜螺十一烷化合物之烷基與芳基衍生物
EP3221315A1 (en) 2014-11-21 2017-09-27 Laboratorios Del. Dr. Esteve, S.A. 1,9-diazaspiro undecane compounds having multimodal activity against pain
US10689398B2 (en) 2015-10-23 2020-06-23 Esteve Pharmaceuticals, S.A. OXA-Diazaspiro compounds having activity against pain

Also Published As

Publication number Publication date
AR106448A1 (es) 2018-01-17
RS59956B1 (sr) 2020-03-31
RU2018118399A (ru) 2019-11-25
HUE047997T2 (hu) 2020-05-28
ME03636B (me) 2020-07-20
RU2018118399A3 (da) 2020-01-31
CA2999925A1 (en) 2017-04-27
TW201731853A (zh) 2017-09-16
SG11201802988XA (en) 2018-05-30
EP3365346A1 (en) 2018-08-29
SI3365346T1 (sl) 2020-04-30
IL258370A (en) 2018-05-31
EP3365346B1 (en) 2019-12-04
TN2018000091A1 (en) 2019-07-08
KR20180073638A (ko) 2018-07-02
JP6884973B2 (ja) 2021-06-09
JP2018531263A (ja) 2018-10-25
BR112018007269A2 (pt) 2018-10-30
US20190002475A1 (en) 2019-01-03
MX2018004777A (es) 2018-06-19
LT3365346T (lt) 2020-04-10
MA43158B1 (fr) 2020-03-31
WO2017067664A1 (en) 2017-04-27
US10689398B2 (en) 2020-06-23
AU2016343551A1 (en) 2018-04-19
PT3365346T (pt) 2020-03-05
CN108349998A (zh) 2018-07-31
HRP20200309T1 (hr) 2020-06-12
ES2775522T3 (es) 2020-07-27
CO2018004803A2 (es) 2018-07-19
WO2017067664A9 (en) 2017-06-29
PH12018500682A1 (en) 2018-10-01
CN108349998B (zh) 2021-10-29
PL3365346T3 (pl) 2020-06-01
CY1122708T1 (el) 2021-03-12

Similar Documents

Publication Publication Date Title
DK3174868T3 (da) Forbindelser, der er aktive mod bromodomæner
BR112017018843A2 (pt) combinações de composto fungicidamente ativo
DK3240773T3 (da) Picolinamidforbindelser med fungicid aktivitet
DK3010910T3 (da) Pyrimidindionforbindelser mod hjertetilstande
DK3267960T3 (da) Stimulationsindretning med forlængelse
DK3474804T4 (da) Medicinsk forbinding
ITUB20153010A1 (it) Pennello perfezionato
DK3337795T3 (da) Piperidinobenzodiazepinforbindelser med anti-proliferativ aktivitet
DK3393478T3 (da) Kombinationsterapi
DK3373874T4 (da) Medicinsk forbinding
DK3167052T3 (da) P450-bm3-varianter med forbedret aktivitet
BR112017013013A2 (pt) combinações de composto ativo
DK3359083T3 (da) Tandbørste
DK3370794T3 (da) Antimikrobielle opløsninger med forbedret stabilitet
ES1141731Y (es) Cepillo de Dientes
DK3352735T3 (da) Olanzapinformuleringer med langvarig frigivelse
DK3331600T3 (da) Kateter
DK3365346T3 (da) Oxa-diazaspiroforbindelser med aktivitet mod smerter
PT3365338T (pt) Derivados de morfolina substituídos tendo atividade contra a dor
DE112016001834A5 (de) Kanüle
DK3484852T3 (da) Benzo-n-hydroxyamidforbindelser med antitumor-aktivitet
DK3359102T3 (da) Medicinsk plaster
DK3244861T3 (da) Tandlægeunit
PT3365345T (pt) Composto de oxa- azaespiro tendo atividade contra a dor
DK3371522T3 (da) Transpireret solfanger